Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News

Table of Contents

The Biology Behind...

  • The Biology Behind...
    Protease Inhibitors in Oral Carcinogenesis and Chemoprevention
    Scott M. Lippman and Lynn M. Matrisian
    Clin Cancer Res December 1 2000 6 (12) 4599-4603;

Editorials

  • Editorials
    Angiogenesis and Lung Cancer: Potential for Therapy
    Roy S. Herbst and Isaiah J. Fidler
    Clin Cancer Res December 1 2000 6 (12) 4604-4606;

Editorial

  • Editorial
    On Receptor Inhibitors and Chemotherapy
    Paula D. Ryan and Bruce A. Chabner
    Clin Cancer Res December 1 2000 6 (12) 4607-4609;

Advances in Brief

  • Advances in Brief
    Paclitaxel-induced Apoptosis and Mitotic Arrest Assessed by Serial Fine-Needle Aspiration: Implications for Early Prediction of Breast Cancer Response to Neoadjuvant Treatment
    W. Fraser Symmans, Matthew D. Volm, Richard L. Shapiro, A. Bridget Perkins, Alice Y. Kim, Sandra Demaria, Herman T. Yee, Heather McMullen, Ruth Oratz, Paula Klein, Silvia C. Formenti and Franco Muggia
    Clin Cancer Res December 1 2000 6 (12) 4610-4617;

  • Advances in Brief
    MDR1 Gene Overexpression and Altered Degree of Methylation at the Promoter Region in Bladder Cancer during Chemotherapeutic Treatment
    Yasuhiro Tada, Morimasa Wada, Kentaro Kuroiwa, Naoko Kinugawa, Taishi Harada, Jun Nagayama, Masayuki Nakagawa, Seiji Naito and Michihiko Kuwano
    Clin Cancer Res December 1 2000 6 (12) 4618-4627;

  • Advances in Brief
    Serum Endostatin Levels Are Elevated and Correlate with Serum Vascular Endothelial Growth Factor Levels in Patients with Stage IV Clear Cell Renal Cancer
    Andrew L. Feldman, Lawrence Tamarkin, Giulio F. Paciotti, Byron W. Simpson, W. Marston Linehan, James C. Yang, William E. Fogler, Ewa M. Turner, H. Richard Alexander Jr. and Steven K. Libutti
    Clin Cancer Res December 1 2000 6 (12) 4628-4634;

  • Advances in Brief
    Expression of Cytoplasmic Galectin-3 as a Prognostic Marker in Tongue Carcinoma
    Yuichiro Honjo, Hidenori Inohara, Shiro Akahani, Tadashi Yoshii, Yukinori Takenaka, Jun-ichi Yoshida, Kenji Hattori, Yoichiro Tomiyama, Avraham Raz and Takeshi Kubo
    Clin Cancer Res December 1 2000 6 (12) 4635-4640;

  • Advances in Brief
    Detection of Germ-Cell Tumor Cells in Peripheral Blood Progenitor Cell Harvests: Impact on Clinical Outcome
    Martin Hildebrandt, Oliver Rick, Abdulgabar Salama, Wolfgang Siegert, Dieter Huhn and Jörg Beyer
    Clin Cancer Res December 1 2000 6 (12) 4641-4646;

  • Advances in Brief
    8pter–p23 Deletion Is Associated with Racial Differences in Prostate Cancer Outcome
    Joseph G. Washburn, Kirk J. Wojno, Jyotirmoy Dey, Isaac J. Powell and Jill A. Macoska
    Clin Cancer Res December 1 2000 6 (12) 4647-4652;

  • Advances in Brief
    Expression of Metastases-associated Genes in Cervical Cancers Resected in the Proliferative and Secretory Phases of the Menstrual Cycle
    Silvia Formenti, Juan Felix, Dennis Salonga, Kathy Danenberg, Malcolm C. Pike and Peter Danenberg
    Clin Cancer Res December 1 2000 6 (12) 4653-4657;

Clinical Trials

  • Clinical Trials
    Vaccination with a Bivalent GM2 and GD2 Ganglioside Conjugate Vaccine: A Trial Comparing Doses of GD2-Keyhole Limpet Hemocyanin
    Paul B. Chapman, Donna Morrisey, Katherine S. Panageas, Linda Williams, Jonathan J. Lewis, Robert J. Israel, W. Bradley Hamilton and Philip O. Livingston
    Clin Cancer Res December 1 2000 6 (12) 4658-4662;

  • Clinical Trials
    Locoregional Cellular Immunotherapy for Patients with Advanced Esophageal Cancer
    Uhi Toh, Hideaki Yamana, Susumu Sueyoshi, Toshiaki Tanaka, Fumihiko Niiya, Katsuko Katagiri, Hiromasa Fujita, Kazuo Shirozou and Kyogo Itoh
    Clin Cancer Res December 1 2000 6 (12) 4663-4673;

  • Clinical Trials
    Phase I Clinical Trial of the Chimeric Monoclonal Antibody (c30.6) in Patients with Metastatic Colorectal Cancer
    Robyn L. Ward, Deborah Packham, Anne M. Smythe, Jayne Murray, Peter Anderson-Stewart, Neil Kitchen, Rosyln Muirhead, Peter Phillips, Peter Gray, Grant Bigg-Wither, Krishnan Prabakaran, Judy Freund, Michael Fullham, Michele Rule, David Dalley, Alan Meagher, Nicholas J. Hawkins and Glenn M. Smith
    Clin Cancer Res December 1 2000 6 (12) 4674-4683;

  • Clinical Trials
    Clinical Modulation of Oral Leukoplakia and Protease Activity by Bowman-Birk Inhibitor Concentrate in a Phase IIa Chemoprevention Trial
    William B. Armstrong, Ann R. Kennedy, X. Steven Wan, Thomas H. Taylor, Quoc A. Nguyen, Jerald Jensen, Wayne Thompson, Westley Lagerberg and Frank L. Meyskens Jr.
    Clin Cancer Res December 1 2000 6 (12) 4684-4691;

  • Clinical Trials
    Pharmacokinetics of the Chemopreventive Agent Oltipraz and of Its Metabolite M3 in Human Subjects after a Single Oral Dose
    Peter J. O’Dwyer, Christine Szarka, James M. Brennan, Paul B. Laub and James M. Gallo
    Clin Cancer Res December 1 2000 6 (12) 4692-4696;

  • Clinical Trials
    A Phase II Study of Razoxane, an Antiangiogenic Topoisomerase II Inhibitor, in Renal Cell Cancer with Assessment of Potential Surrogate Markers of Angiogenesis
    Jeremy P. Braybrooke, Kenneth J. O’Byrne, David J. Propper, Andrew Blann, Mark Saunders, Nicola Dobbs, Cheng Han, Jane Woodhull, Karen Mitchell, Jeremy Crew, Kenneth Smith, Ross Stephens, Trivadi S. Ganesan, Denis C. Talbot and Adrian L. Harris
    Clin Cancer Res December 1 2000 6 (12) 4697-4704;

  • Clinical Trials
    Clinical Implications of Dihydropyrimidine Dehydrogenase (DPD) Deficiency in Patients with Severe 5-Fluorouracil-associated Toxicity: Identification of New Mutations in the DPD Gene
    André B. P. van Kuilenburg, Janet Haasjes, Dick J. Richel, Lida Zoetekouw, Henk Van Lenthe, Ronney A. De Abreu, Jan G. Maring, Peter Vreken and Albert H. van Gennip
    Clin Cancer Res December 1 2000 6 (12) 4705-4712;

  • Clinical Trials
    White Blood Cell Count: A Prognostic Factor and Possible Subset Indicator of Optimal Treatment with Low-Dose Adjuvant Interferon in Primary Melanoma
    Pauline de La Salmonière, Jean-Jacques Grob, Brigitte Dreno, Michèle Delaunay and Claude Chastang
    Clin Cancer Res December 1 2000 6 (12) 4713-4718;

  • Clinical Trials
    Phase I/II Study of G17-DT, an Anti-Gastrin Immunogen, in Advanced Colorectal Cancer
    Andrew M. Smith, Timothy Justin, Dor Michaeli and Susan A. Watson
    Clin Cancer Res December 1 2000 6 (12) 4719-4724;

  • Clinical Trials
    Pharmacokinetics and Pharmacodynamics of the Novel Marine-derived Anticancer Agent Ecteinascidin 743 in a Phase I Dose-finding Study
    Charlotte van Kesteren, Esteban Cvitkovic, Adelkrim Taamma, Luis López-Lázaro, Jośe M. Jimeno, Cecilia Guzman, Ron A. A. Mathôt, Jan H. M. Schellens, Jean-Louis Misset, Etienne Brain, Michael J. X. Hillebrand, Hilde Rosing and Jos H. Beijnen
    Clin Cancer Res December 1 2000 6 (12) 4725-4732;

  • Clinical Trials
    Multi-Institutional Validation Study of Carboplatin Dosing Formula Using Adjusted Serum Creatinine Level
    Masahiko Ando, Hironobu Minami, Yuichi Ando, Hideo Saka, Shuzo Sakai, Masashi Yamamoto, Yasutsuna Sasaki, Kaoru Shimokata and Yoshinori Hasegawa
    Clin Cancer Res December 1 2000 6 (12) 4733-4738;

Molecular Oncology, Markers, Clinical Correlates

  • Molecular Oncology, Markers, Clinical Correlates
    Nitric Oxide Synthase, Cyclooxygenase 2, and Vascular Endothelial Growth Factor in the Angiogenesis of Non-Small Cell Lung Carcinoma
    Aizen J. Marrogi, William D. Travis, Judith A. Welsh, Mohammed A. Khan, Haress Rahim, Henry Tazelaar, Peter Pairolero, Victor Trastek, James Jett, Neil E. Caporaso, Lance A. Liotta and Curtis C. Harris
    Clin Cancer Res December 1 2000 6 (12) 4739-4744;

  • Molecular Oncology, Markers, Clinical Correlates
    Relationship between c-erbB-2 and Other Tumor Characteristics in Breast Cancer Prognosis
    Magali Ferrero-Poüs, Kamel Hacène, Cécile Bouchet, Viviane Le Doussal, Michèle Tubiana-Hulin and Frédérique Spyratos
    Clin Cancer Res December 1 2000 6 (12) 4745-4754;

  • Molecular Oncology, Markers, Clinical Correlates
    Spontaneous Apoptosis in Advanced Esophageal Carcinoma: Its Relation to Fas Expression
    Muneaki Shibakita, Mitsuo Tachibana, Dipok K. Dhar, Satoshi Ohno, Hirofumi Kubota, Hiroshi Yoshimura, Shoichi Kinugasa, Reiko Masunaga and Naofumi Nagasue
    Clin Cancer Res December 1 2000 6 (12) 4755-4759;

  • Molecular Oncology, Markers, Clinical Correlates
    Detection of Epidermal Growth Factor Receptor in the Serum of Patients with Cervical Carcinoma
    Min-Jeong Oh, Jin-Hyuk Choi, In Ho Kim, Yong Ho Lee, Joon Yong Huh, Yong Kyun Park, Kyu Wan Lee, Soo Yong Chough, Kap Soon Joo, Byung Sam Ku and Ho-Suk Saw
    Clin Cancer Res December 1 2000 6 (12) 4760-4763;

  • Molecular Oncology, Markers, Clinical Correlates
    PGP9.5 as a Prognostic Factor in Pancreatic Cancer
    Ekmel Tezel, Kenji Hibi, Tetsuro Nagasaka and Akimasa Nakao
    Clin Cancer Res December 1 2000 6 (12) 4764-4767;

  • Molecular Oncology, Markers, Clinical Correlates
    Inducible Nitric Oxide Synthase and Nitrotyrosine in Human Metastatic Melanoma Tumors Correlate with Poor Survival
    Suhendan Ekmekcioglu, Julie Ellerhorst, Christine M. Smid, Victor G. Prieto, Mark Munsell, Antonio C. Buzaid and Elizabeth A. Grimm
    Clin Cancer Res December 1 2000 6 (12) 4768-4775;

  • Molecular Oncology, Markers, Clinical Correlates
    Telomerase Activity in Soft-Tissue and Bone Sarcomas
    Kenjiro Aogi, Anthony Woodman, Virginia Urquidi, David C. Mangham, David Tarin and Steve Goodison
    Clin Cancer Res December 1 2000 6 (12) 4776-4781;

  • Molecular Oncology, Markers, Clinical Correlates
    Loss of Heterozygosity and Microsatellite Instability as Predictive Markers for Neoadjuvant Treatment in Gastric Carcinoma
    Tobias Grundei, Holger Vogelsang, Katja Ott, James Mueller, Michael Scholz, Karen Becker, Ulrich Fink, Jörg Rüdiger Siewert, Heinz Höfler and Gisela Keller
    Clin Cancer Res December 1 2000 6 (12) 4782-4788;

  • Molecular Oncology, Markers, Clinical Correlates
    Expression of E-cadherin and β-Catenin in Human Non-Small Cell Lung Cancer and the Clinical Significance
    Shinichiro Kase, Kenji Sugio, Koji Yamazaki, Tatsuro Okamoto, Tokujiro Yano and Keizo Sugimachi
    Clin Cancer Res December 1 2000 6 (12) 4789-4796;

  • Molecular Oncology, Markers, Clinical Correlates
    Thymidylate Synthase Protein Expression in Primary Colorectal Cancer Compared with the Corresponding Distant Metastases and Relationship with the Clinical Response to 5-Fluorouracil
    Carlo Aschele, Domizia Debernardis, Gianni Tunesi, Frank Maley and Alberto Sobrero
    Clin Cancer Res December 1 2000 6 (12) 4797-4802;

  • Molecular Oncology, Markers, Clinical Correlates
    Expression of the Human Telomerase Reverse Transcriptase Is Not Related to Telomerase Activity in Normal and Malignant Renal Tissue
    Volker Rohde, Hans-Peter Sattler, Thorsten Bund, Helmut Bonkhoff, Thomas Fixemer, Christa Bachmann, Ramona Lensch, Gerhard Unteregger, Michael Stoeckle and Bernd Wullich
    Clin Cancer Res December 1 2000 6 (12) 4803-4809;

  • Molecular Oncology, Markers, Clinical Correlates
    A Genetic Epidemiological Study of Hereditary Prostate Cancer (HPC) in Finland: Frequent HPCX Linkage in Families with Late-onset Disease
    Johanna Schleutker, Mika Matikainen, Jeffrey Smith, Pasi Koivisto, Agnes Baffoe-Bonnie, Tommi Kainu, Elizabeth Gillanders, Risto Sankila, Eero Pukkala, John Carpten, Dietrich Stephan, Teuvo Tammela, Michael Brownstein, Joan Bailey-Wilson, Jeffrey Trent and Olli-P. Kallioniemi
    Clin Cancer Res December 1 2000 6 (12) 4810-4815;

  • Molecular Oncology, Markers, Clinical Correlates
    p27Kip1 Expression Is Associated with Clinical Outcome in Advanced Epithelial Ovarian Cancer: Multivariate Analysis
    Valeria Masciullo, Gabriella Ferrandina, Bruna Pucci, Francesco Fanfani, Silvia Lovergine, Juan Palazzo, Gianfranco Zannoni, Salvatore Mancuso, Giovanni Scambia and Antonio Giordano
    Clin Cancer Res December 1 2000 6 (12) 4816-4822;

  • Molecular Oncology, Markers, Clinical Correlates
    Interstitial Collagenases as Markers of Tumor Progression
    Constance E. Brinckerhoff, Joni L. Rutter and Ulrike Benbow
    Clin Cancer Res December 1 2000 6 (12) 4823-4830;

  • Molecular Oncology, Markers, Clinical Correlates
    Paucity of Functional T-Cell Memory to Melanoma Antigens in Healthy Donors and Melanoma Patients
    Madhav V. Dhodapkar, James W. Young, Paul B. Chapman, William I. Cox, Jean Francois Fonteneau, Sebastian Amigorena, Alan N. Houghton, Ralph M. Steinman and Nina Bhardwaj
    Clin Cancer Res December 1 2000 6 (12) 4831-4838;

  • Molecular Oncology, Markers, Clinical Correlates
    Preferential Adhesion of Prostate Cancer Cells to Bone Is Mediated by Binding to Bone Marrow Endothelial Cells as Compared to Extracellular Matrix Components in Vitro
    Carlton R. Cooper, Lisa McLean, Michael Walsh, Jeremy Taylor, Satoru Hayasaka, Jasmine Bhatia and Kenneth J. Pienta
    Clin Cancer Res December 1 2000 6 (12) 4839-4847;

  • Molecular Oncology, Markers, Clinical Correlates
    The Angiogenesis Inhibitor SU5416 Has Long-lasting Effects on Vascular Endothelial Growth Factor Receptor Phosphorylation and Function
    Dirk B. Mendel, Randall E. Schreck, David C. West, Guangmin Li, Laurie M. Strawn, Sheila S. Tanciongco, Stefan Vasile, Laura K. Shawver and Julie M. Cherrington
    Clin Cancer Res December 1 2000 6 (12) 4848-4858;

  • Molecular Oncology, Markers, Clinical Correlates
    CDC25B and p53 Are Independently Implicated in Radiation Sensitivity for Human Esophageal Cancers
    Hiroshi Miyata, Yuichiro Doki, Hitoshi Shiozaki, Msatoshi Inoue, Msahiko Yano, Yoshiyuki Fujiwara, Hirofumi Yamamoto, Kiyonori Nishioka, Kentaro Kishi and Morito Monden
    Clin Cancer Res December 1 2000 6 (12) 4859-4865;

  • Molecular Oncology, Markers, Clinical Correlates
    The Prognostic Value of Angiogenesis Factor Expression for Predicting Recurrence and Metastasis of Bladder Cancer after Neoadjuvant Chemotherapy and Radical Cystectomy
    Keiji Inoue, Joel W. Slaton, Takashi Karashima, Chiaki Yoshikawa, Taro Shuin, Paul Sweeney, Randall Millikan and Colin P. N. Dinney
    Clin Cancer Res December 1 2000 6 (12) 4866-4873;

Experimental Therapeutics, Preclinical Pharmacology

  • Experimental Therapeutics, Preclinical Pharmacology
    Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma
    Keiji Inoue, Joel W. Slaton, Paul Perrotte, Darren W. Davis, Christiane J. Bruns, Daniel J. Hicklin, David J. McConkey, Paul Sweeney, Robert Radinsky and Colin P. N. Dinney
    Clin Cancer Res December 1 2000 6 (12) 4874-4884;

  • Experimental Therapeutics, Preclinical Pharmacology
    Efficacy of Cytotoxic Agents against Human Tumor Xenografts Is Markedly Enhanced By Coadministration of ZD1839 (Iressa), an Inhibitor of EGFR Tyrosine Kinase
    Francis M. Sirotnak, Maureen F. Zakowski, Vincent A. Miller, Howard I. Scher and Mark G. Kris
    Clin Cancer Res December 1 2000 6 (12) 4885-4892;

  • Experimental Therapeutics, Preclinical Pharmacology
    Cross-Resistance of Triphenylethylene-type Antiestrogens but not ICI 182,780 in Tamoxifen-stimulated Breast Tumors Grown in Athymic Mice
    Eun Sook Lee, Jennifer MacGregor Schafer, Kathy Yao, Gale England, Ruth M. O’Regan, Alexander De Los Reyes and V. Craig Jordan
    Clin Cancer Res December 1 2000 6 (12) 4893-4899;

  • Experimental Therapeutics, Preclinical Pharmacology
    Cure of Metastatic Human Colonic Cancer in Mice with Radiolabeled Monoclonal Antibody Fragments
    Thomas M. Behr, Rosalyn D. Blumenthal, Stavros Memtsoudis, Robert M. Sharkey, Stefan Gratz, Wolfgang Becker and David M. Goldenberg
    Clin Cancer Res December 1 2000 6 (12) 4900-4907;

  • Experimental Therapeutics, Preclinical Pharmacology
    Efficacy with a Replication-selective Adenovirus Plus Cisplatin-based Chemotherapy: Dependence on Sequencing but not p53 Functional Status or Route of Administration
    Carla Heise, Marilyn Lemmon and David Kirn
    Clin Cancer Res December 1 2000 6 (12) 4908-4914;

  • Experimental Therapeutics, Preclinical Pharmacology
    Antisense of Human Peroxiredoxin II Enhances Radiation-induced Cell Death
    Sun-Hee Park, Young Min Chung, Yong-Sik Lee, Hyung Jung Kim, Jun Suk Kim, Ho Zoon Chae and Young Do Yoo
    Clin Cancer Res December 1 2000 6 (12) 4915-4920;

  • Experimental Therapeutics, Preclinical Pharmacology
    In Vivo Targeting of Malignant Melanoma by 125Iodine- and 99mTechnetium-labeled Single-chain Fv Fragments against High Molecular Weight Melanoma-associated Antigen
    Norbert Kang, Stephen Hamilton, Joy Odili, George Wilson and Jörg Kupsch
    Clin Cancer Res December 1 2000 6 (12) 4921-4931;

  • Experimental Therapeutics, Preclinical Pharmacology
    Response and Determinants of Sensitivity to Paclitaxel in Human Non-Small Cell Lung Cancer Tumors Heterotransplanted in Nude Mice
    Roman Perez-Soler, Bonnie Kemp, Qing Ping Wu, Li Mao, Jorge Gomez, Anne Zeleniuch-Jacquotte, Herman Yee, Jin Soo Lee, Jaishree Jagirdar and Yi He Ling
    Clin Cancer Res December 1 2000 6 (12) 4932-4938;

  • Experimental Therapeutics, Preclinical Pharmacology
    Pegylated Liposome-encapsulated Doxorubicin and Cisplatin Enhance the Effect of Radiotherapy in a Tumor Xenograft Model
    Kevin J. Harrington, Gail Rowlinson-Busza, Konstantinos N. Syrigos, Richard G. Vile, Paul S. Uster, A. Michael Peters and J. Simon W. Stewart
    Clin Cancer Res December 1 2000 6 (12) 4939-4949;

  • Experimental Therapeutics, Preclinical Pharmacology
    The Addition of Bryostatin 1 to Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Chemotherapy Improves Response in a CHOP-resistant Human Diffuse Large Cell Lymphoma Xenograft Model
    Ramzi M. Mohammad, Nathan R. Wall, Julie A. Dutcher and Ayad M. Al-Katib
    Clin Cancer Res December 1 2000 6 (12) 4950-4956;

Cancer Biology, Immunology, Cytokines

  • Cancer Biology, Immunology, Cytokines
    Arsenic Trioxide-mediated Cytotoxicity and Apoptosis in Prostate and Ovarian Carcinoma Cell Lines
    Ruchan Uslu, Ulus Ali Sanli, Canfeza Sezgin, Bulent Karabulut, Ender Terzioglu, Serdar Bedii Omay and Erdem Goker
    Clin Cancer Res December 1 2000 6 (12) 4957-4964;

Letter to the Editor

  • Letter to the Editor
    Correspondence re: M. Kondo et al., Increased Expression of COX-2 in Nontumor Liver Tissue Is Associated with Shorter Disease-free Survival in Patients with Hepatocellular Carcinoma. Clin. Cancer Res., 5: 4005–4012, 1999.
    Tohru Utsunomiya, Mitsuo Shimada, Tatsuya Rikimaru, Keizo Sugimachi, Ken-Ichi Ohkura, Shihoko Kaku, Koji Yamada and Ken-Ichi Taguchi
    Clin Cancer Res December 1 2000 6 (12) 4965-4966;

Errata

  • Errata
    Erratum/Correction
    Clin Cancer Res December 1 2000 6 (12) 4967-4967;

Back to top
PreviousNext
December 2000
Volume 6, Issue 12
  • Table of Contents

Sign up for alerts

Jump to

  • The Biology Behind...
  • Editorials
  • Editorial
  • Advances in Brief
  • Clinical Trials
  • Molecular Oncology, Markers, Clinical Correlates
  • Experimental Therapeutics, Preclinical Pharmacology
  • Cancer Biology, Immunology, Cytokines
  • Letter to the Editor
  • Errata
Advertisement
  • Most Cited
  • Most Read
Loading
  • Targeted TNF Potentiates the Efficacy of a Peptide Vaccine
  • WNT/β-catenin–Associated Immune Exclusion across Cancers
  • Alisertib for Neuroendocrine Prostate Cancer
  • Genotyping of HCC in the Clinic
  • Single-Cell RNA Sequencing of Pancreatic Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement